Members of the ABCB, ABCC, and ABCG families are well-established mediators of therapy resistance [49], and recent studies have also implicated ABCA6 and ABCA8 in drug resistance in pancreatic cancer [10]. This evidence concerns the gene ABCA8 and familial pancreatic carcinoma.